1. Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA;
2. Department of Pathology, Massachusetts General Hospital, Boston, MA;
3. Broad Institute, Cambridge, MA;
4. Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA;
5. Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA;
6. Agilent Technologies, Santa Clara, CA;
7. Ottawa Blood Disease Centre, The Ottawa Hospital, Ottawa, ON, Canada; and
8. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA